{
    "organizations": [],
    "uuid": "35d971aa64fe46bdf3cade1e6351ff68804682b3",
    "author": "",
    "url": "https://www.reuters.com/article/brief-beigene-and-boehringer-ingelheim-a/brief-beigene-and-boehringer-ingelheim-announce-commercial-supply-agreement-for-tislelizumab-idUSASB0C0E3",
    "ord_in_thread": 0,
    "title": "BRIEF-Beigene And Boehringer Ingelheim Announce Commercial Supply Agreement For Tislelizumab",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 9, 2018 / 2:20 PM / Updated 6 minutes ago BRIEF-Beigene And Boehringer Ingelheim Announce Commercial Supply Agreement For Tislelizumab Reuters Staff \nJan 9 (Reuters) - Beigene Ltd: \n* BEIGENE AND BOEHRINGER INGELHEIM ANNOUNCE COMMERCIAL SUPPLY AGREEMENT FOR ANTI-PD-1 ANTIBODY TISLELIZUMAB \n* BEIGENE LTD - BOEHRINGER INGELHEIM WILL MANUFACTURE TISLELIZUMAB IN CHINA UNDER AN EXCLUSIVE MULTI-YEAR ARRANGEMENT, WITH CONTRACT EXTENSION POSSIBLE \n* BEIGENE LTD - CO ALSO OBTAINED CERTAIN PREFERRED RIGHTS FOR FUTURE CAPACITY EXPANSION BY BOEHRINGER INGELHEIM IN CHINA Source text for Eikon: Further company coverage:",
    "published": "2018-01-09T16:20:00.000+02:00",
    "crawled": "2018-01-09T16:33:12.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "boehringer",
        "ingelheim",
        "announce",
        "commercial",
        "supply",
        "agreement",
        "tislelizumab",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "beigene",
        "ltd",
        "beigene",
        "boehringer",
        "ingelheim",
        "announce",
        "commercial",
        "supply",
        "agreement",
        "antibody",
        "tislelizumab",
        "beigene",
        "ltd",
        "boehringer",
        "ingelheim",
        "manufacture",
        "tislelizumab",
        "china",
        "exclusive",
        "arrangement",
        "contract",
        "extension",
        "possible",
        "beigene",
        "ltd",
        "co",
        "also",
        "obtained",
        "certain",
        "preferred",
        "right",
        "future",
        "capacity",
        "expansion",
        "boehringer",
        "ingelheim",
        "china",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}